Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05653570

Electrical Stimulation for Erector Spinae Plane Catheter Insertion

The erector spinae plane (ESP) block has been studied for analgesia in shoulder surgery as a phrenic nerve-sparing alternative. However, successful ESP catheter placement appears multifactorial, with failure mechanisms including lamination, plane collapse, or catheter overcoiling. Electrical stimulation (ES) is a common technique used in regional anesthesia to detect possible intraneural placement. ES of the erector spinae muscle complex may objectively guide proper interfascial catheter placement and improve local anesthetic spread. The primary goal of this study is to establish if ESP catheter placement with the addition of ES to ultrasound (US) guidance facilitates accurate catheter placement. This study will further characterize postoperative analgesia and the incidence of brachial plexus stimulation for patients who receive ES-assisted ESP catheter placement.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elective total or total reverse shoulder arthroplasty

Exclusion criteria

  • inability to provide consent
  • history of active opioid use
  • emergency procedures
  • shoulder arthroscopy
  • partial shoulder replacement
  • shoulder resurfacing
  • any revision shoulder surgery
  • any indwelling deep brain stimulator, pacemaker, and/or other neurostimulators

Treatment and study plan

Electrical stimulation

Diagnostic Test

Electrical stimulation will be used to confirm needle and catheter placement within the interfascial plane between the erector spinae muscle and thoracic transverse process.

Ultrasound

Diagnostic Test

Ultrasound guidance will be used to visualize needle and catheter placement within the interfascial plane between the erector spinae muscle and thoracic transverse process.

Primary outcomes

  1. Number of patients with erector spinae muscle stimulation via stimulating catheter

    Time frame: Immediately after catheter placement (up to 5 minutes to assess)

    Successful erector spinae plane needle and catheter insertion means that the needle/catheter is deep to the myofascia of the erector spinae muscle complex and superficial to the intertransverse ligaments / transverse process. Thus, any stimulation of the catheter after its placement in the erector spinae muscle complex seen under ultrasound or perceived by the patient will be documented as catheter placement failure. No visualized or perceived stimulation of the erector spinae muscle complex will be documented as catheter placement success.

Secondary outcomes

  1. Time to perform erector spinae plane catheter

    Time frame: During catheter placement (up to 20 minutes)

    Time for catheter placement will begin when the US probe first touches the patient and end when the inner stimulating catheter hub meets the skin. If no visual identification of the target erector spinae plane (US) and no evoked motor respoinse (US+ES) is achieved within 10 minutes, the placement will be considered a failure, and the primary end point will be recorded as 10 minutes. If a catheter cannot be placed per protocol within 20 minutes, the placement will be considered a failure, and the primary endpoint will be recorded as 20 minutes. In such cases, the subject will have a catheter placement attempt using the alternative method. Subjects who do not have a catheter placed as per their randomized group protocol will be removed from further study.

  2. Worst pain score ratings in the postanesthesia care unit (PACU)

    Time frame: as soon as patient can respond in PACU (up to 1 hour)

    As soon as the patient is able to respond verbally in the PACU, the subject will be asked to rate their pain on an 11-point numeric rating scale (NRS, 0 being no pain and 10 being worst possible pain)

  3. Highest and lowest vertebral level of sensory change after local anesthetic bolus

    Time frame: preoperatively, 30 minutes after local anesthetic bolus

    We will administer cold spray (name, manufacturer location) 3 cm lateral to the spinous process from C1 to T12, and document the highest and lowest dermatomal levels of when the patient detects a difference in temperature sensation compared to the contralateral side.

  4. Incidence of brachial plexus or intercostal stimulation via stimulating catheter before local anesthetic bolus

    Time frame: preoperatively, prior to local anesthetic bolus (up to 5 minutes)

    Prior to local anesthetic bolus, any perceived stimulation of an intercostal muscle or in the distribution of the brachial plexus on the operative side, including but not limited to twitching of or warmth of skin overlying the deltoid, biceps, triceps, supraspinatus, infraspinatus, pectoralis major/minor, and teres major/minor, will be documented.

  5. Incidence of brachial plexus or intercostal stimulation via stimulating catheter after local anesthetic bolus

    Time frame: preoperatively, 30 minutes after local anesthetic bolus

    30 minutes after local anesthetic bolus, any perceived stimulation of an intercostal muscle or in the distribution of the brachial plexus on the operative side, including but not limited to twitching of or warmth of skin overlying the deltoid, biceps, triceps, supraspinatus, infraspinatus, pectoralis major/minor, and teres major/minor, will be documented.

  6. Opioid consumption in the PACU

    Time frame: from admission to discharge from the PACU (average approximately 2 hours)

    The subject's total opioid administration in the PACU will be documented and converted to oral morphine milliequivalents (MME).

  7. Opioid consumption on postoperative day (POD) 1

    Time frame: POD1 (24 hours)

    The subject's total opioid administration on POD1 will be documented and converted to oral morphine milliequivalents (MME).

  8. Opioid consumption on postoperative day (POD) 2

    Time frame: POD2 (24 hours)

    The subject's total opioid administration on POD2 will be documented and converted to oral morphine milliequivalents (MME).

  9. Opioid consumption on postoperative day (POD) 3

    Time frame: POD3 (24 hours)

    The subject's total opioid administration on POD3 will be documented and converted to oral morphine milliequivalents (MME).

  10. Average postoperative pain on postoperative day (POD) 1

    Time frame: POD1 (24 hours)

    The subject's average postoperative pain score ratings will be calculated on POD 1. Pain scored on an 11-point numeric rating scale (NRS, 0 being no pain and 10 being worst possible pain)

  11. Average postoperative pain on postoperative day (POD) 2

    Time frame: POD2 (24 hours)

    The subject's average postoperative pain score ratings will be calculated on POD 2 Pain scored on an 11-point numeric rating scale (NRS, 0 being no pain and 10 being worst possible pain)

  12. Average postoperative pain on postoperative day (POD) 3

    Time frame: POD3 (24 hours)

    The subject's average postoperative pain score ratings will be calculated on POD 3 Pain scored on an 11-point numeric rating scale (NRS, 0 being no pain and 10 being worst possible pain)

Study contacts

Contact information is provided by the study sponsor or research team.

Jan Boublik, MD

CONTACT

[email protected]

(917) 617-6261

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Official study title

Electrical Stimulation for Erector Spinae Plane Catheter Insertion: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 16, 2022
Registry last updated
Apr 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.